Trials / Conditions / Birch Pollen Allergy

Birch Pollen Allergy

19 registered clinical trials studyying Birch Pollen Allergy.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Study of DM-101PX in Adults With Birch Pollen Allergy NCT07254871	Desentum Oy	Phase 2
Completed	Evaluation of an Adjusted Cutoff Value for S.P.A.T (Skin Prick Automated Test) Device in Allergic Subjects NCT06803953	Hippocreates	N/A
Completed	Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Ast NCT05668390	Stallergenes Greer	Phase 3
Completed	Study to Evaluate Safety, Tolerability and Explorative Efficacy of DM-101PX in Birch Pollen Allergic Participa NCT06037148	Desentum Oy	Phase 1
Completed	Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis NCT05346718	Fraunhofer-Institute of Toxicology and Experimental Medicine	N/A
Completed	Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy NCT04435678	MacroArray Diagnostics GmbH	N/A
Completed	Study to Evaluate Safety and Tolerability of sc Immunotherapy With DM-101 in Adults With Birch Pollen Allergy NCT04266028	Desentum Oy	Phase 1
Completed	Study to Assess the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of a Single Dose of REG NCT03969849	Regeneron Pharmaceuticals	Phase 1
Completed	S.C. Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen NCT04912076	Odense University Hospital	Phase 1
Unknown	Effect of the Nasal Provocation on the Breathing Style NCT02146300	Oulu University Hospital	N/A
Completed	Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Trea NCT02143583	Anergis	—
Completed	Comparison of the Influence of Different Skin Conditions on the Allergic Skin Reactivity to Epicutanous Allerg NCT02074930	University of Zurich	N/A
Completed	A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy Tablet NCT01675791	ALK-Abelló A/S	Phase 2
Completed	Physiological Study to Determine the Allergic Skin Activity After Different Skin Preparation NCT01628484	University of Zurich	Phase 1
Completed	Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy NCT01449786	Medical University of Vienna	Phase 2
Completed	SUBLIVAC® Birch PROBE Study NCT00932607	HAL Allergy	Phase 2
Completed	Probiotics for Reduction Of Markers In Subjects With Allergy NCT01137357	Rijnstate Hospital	N/A
Completed	Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis NCT00309062	Allergopharma GmbH & Co. KG	Phase 3
Completed	Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV NCT00266526	Allergopharma GmbH & Co. KG	Phase 2